cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer-Reference-Cited by-同舟云学术

cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer

Published:2023 Issue:7 Volume:8 Page:870-886
ISSN:2055-6756
Container-title:Nanoscale Horizons
language:en
Short-container-title:Nanoscale Horiz.

Author:

Zou Chenming¹^ORCID,Tang Yuepeng¹,Zeng Ping¹,Cui Derong²,Amili Majdi Al¹,Chang Ya¹,Jin Zhu¹,Shen Yuanyuan¹,Tan Songwei³^ORCID,Guo Shengrong¹^ORCID

Affiliation:

1. School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China

2. Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai 200233, China

3. School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China

Abstract

cRGD-modified nanoparticles (cRGD-TDA NPs) of a multi-bioactive agent conjugate for powerfully eliciting an immunogenic cell death (ICD) effect and enhancing cancer chemoimmunotherapy combined with PD-L1 antagonists.

Funder

National Natural Science Foundation of China

Shanghai Jiao Tong University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NH/D2NH00590E

Reference73 articles.

1. Microenvironmental regulation of tumor progression and metastasis

2. Breast cancer